Catherine R. Kostlan

1.1k citations

25 papers · 838 indexed · h-index 11

Organic Chemistry top 5%
Molecular Biology
Pharmacology top 10%
Epidemiology
Computational Theory and Mathematics top 10%

Co-authors: Denis J. Schrier Richard D. Dyer Michael D. Mullican Michael W. Wilson Jagadish C. Sircar David T. Connor Clifford D. Wright Wiaczeslaw A. Cetenko
Topics: Synthesis and biological activity (8 papers)Synthesis and Reactions of Organic Compounds (8 papers)Nail Diseases and Treatments (5 papers)
Cited by: Organic Chemistry Pharmacology Physiology
Journals: Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Advances in experimental medicine and biology
Partner nations: United States Germany United Kingdom

In The Last Decade

Catherine R. Kostlan

25 papers receiving 798 citations

Peers

Countries citing papers authored by Catherine R. Kostlan

Since Specialization

Citations

This map shows the geographic impact of Catherine R. Kostlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine R. Kostlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine R. Kostlan more than expected).

Fields of papers citing papers by Catherine R. Kostlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine R. Kostlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine R. Kostlan. The network helps show where Catherine R. Kostlan may publish in the future.

Co-authorship network of co-authors of Catherine R. Kostlan

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine R. Kostlan. A scholar is included among the top collaborators of Catherine R. Kostlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine R. Kostlan. Catherine R. Kostlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pantolactams as androgen receptor antagonists for the topical suppression of sebum production 2011 ·Bioorganic & Medicinal Chemistry Letters ·Karen E. Sexton,(unknown),(unknown),(unknown),(unknown),(unknown),Stephen A. Fakhoury,(unknown),Lain‐Yen Hu,Catherine R. Kostlan,David Pocalyko,(unknown),(unknown),Veerabahu Shanmugasundaram,(unknown)	4
2	Succinic acid amides as P2–P3 replacements for inhibitors of interleukin-1β converting enzyme (ICE or caspase 1) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul Galatsis,Bradley W. Caprathe,John L. Gilmore,(unknown),(unknown),Susan Sheehan,William G. Harter,Catherine R. Kostlan,Elizabeth A. Lunney,Charles J. Stankovic,John R. Rubin,Kenneth D. Brady,Hamish Allen,Robert V. Talanian	16
3	Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul Galatsis,Bradley W. Caprathe,Dennis M. Downing,John L. Gilmore,William G. Harter,Sheryl J. Hays,Catherine R. Kostlan,(unknown),Elizabeth A. Lunney,(unknown),(unknown),Joseph S. Warmus,Hamish Allen,Kenneth D. Brady,Robert V. Talanian,Nigel P.C. Walker	6
4	Rational Design of a Topical Androgen Receptor Antagonist for the Suppression of Sebum Production with Properties Suitable for Follicular Delivery 2010 ·Journal of Medicinal Chemistry ·Lorna H. Mitchell,Theodore R. Johnson,Guang Wei Lu,(unknown),Kaushik Datta,(unknown),Veerabahu Shanmugasundaram,Julie K. Spence,(unknown),Zhi Wang,(unknown),(unknown),Lain‐Yen Hu,Karen E. Sexton,(unknown),Catherine R. Kostlan,David Pocalyko	11
5	4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production 2009 ·Bioorganic & Medicinal Chemistry Letters ·Lorna H. Mitchell,Zhi Wang,Lain‐Yen Hu,Catherine R. Kostlan,(unknown),(unknown),(unknown),David Pocalyko,(unknown)	10
6	Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production 2009 ·Bioorganic & Medicinal Chemistry Letters ·Lorna H. Mitchell,Lain‐Yen Hu,Maria Nguyen,Stephen A. Fakhoury,(unknown),Donna M. Iula,Catherine R. Kostlan,(unknown),(unknown),(unknown),David Pocalyko,(unknown),Bruce A. Lefker	7
7	Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Lain‐Yen Hu,Catherine R. Kostlan,Bruce A. Lefker,Jie Li,Lorna H. Mitchell,Zhi Wang,(unknown),(unknown),(unknown),(unknown),David Pocalyko,(unknown)	9
8	The design and synthesis of sulfonamides as caspase-1 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·William G. Harter,(unknown),Kenneth D. Brady,Bradley W. Caprathe,James B. Dunbar,John L. Gilmore,Sheryl J. Hays,Catherine R. Kostlan,(unknown),Nigel P.C. Walker	53
9	Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1) 2002 ·Bioorganic & Medicinal Chemistry ·Aurash Shahripour,Mark S. Plummer,Elizabeth A. Lunney,Hans Albrecht,Sheryl J. Hays,Catherine R. Kostlan,Tomi K. Sawyer,Nigel P.C. Walker,Kenneth D. Brady,Hamish Allen,Robert V. Talanian,Winnie W. Wong,Christine Humblet	21
10	Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity 1994 ·Journal of Medicinal Chemistry ·Paul C. Unangst,David T. Connor,Wiaczeslaw A. Cetenko,Roderick J. Sorenson,Catherine R. Kostlan,Jagadish C. Sircar,Clifford D. Wright,Denis J. Schrier,Richard D. Dyer	138
11	Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents 1993 ·Journal of Medicinal Chemistry ·Michael D. Mullican,Michael W. Wilson,(unknown),Catherine R. Kostlan,Denis J. Schrier,Richard D. Dyer	337
12	Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-l-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H-imidazole-5-carboxylic acid (CI-996) 1993 ·Journal of Medicinal Chemistry ·Ila Sircar,John C. Hodges,John Quin,Amy Bunker,R. Thomas Winters,Jeremy J. Edmunds,Catherine R. Kostlan,Cleo J. C. Connolly,S. Kesten	5
13	Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d]pyrimidin-4-one (CI-972) 1992 ·Journal of Medicinal Chemistry ·Jagadish C. Sircar,Catherine R. Kostlan,Richard B. Gilbertsen,Mark K. Bennett,(unknown),(unknown)	25
14	Styrylpyrazoles, styrylisoxazoles, and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors 1991 ·Journal of Medicinal Chemistry ·Darren Flynn,Thomas R. Belliotti,Amal M. Boctor,D. T. CONNOR,Catherine R. Kostlan,D E Nies,Daniel F. Ortwine,Denis J. Schrier,Jagadish C. Sircar	83
15	Biochemical and Pharmacological Properties of CI-972, a Novel 9-Deazaguanine Analog Purine Nucleoside Phosphorylase (PNP) Inhibitor 1991 ·Advances in experimental medicine and biology ·Richard B. Gilbertsen,(unknown),(unknown),(unknown),Jagadish C. Sircar,Catherine R. Kostlan,Mary Carol Conroy	6
16	Pyrrolo[3,2-D]Pyrimidines, a New Class of Purine Nucleoside Phosphorylase (PNP) Inhibitors as Potential T-Cell Selective Immunosuppressive Agents 1991 ·Advances in experimental medicine and biology ·Jagadish C. Sircar,Catherine R. Kostlan,Richard B. Gilbertsen,(unknown),Wiaczeslaw A. Cetenko	8
17	ChemInform Abstract: Styrylpyrazoles, Styrylisoxazoles, and Styrylisothiazoles. Novel 5‐ Lipoxygenase and Cyclooxygenase Inhibitors. 1991 ·ChemInform ·Darren Flynn,Thomas R. Belliotti,Amal M. Boctor,D. T. CONNOR,Catherine R. Kostlan,D E Nies,Daniel F. Ortwine,Denis J. Schrier,Jagadish C. Sircar	1
18	Nonsteroidal anti-inflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase 1990 ·Journal of Medicinal Chemistry ·Daniel L. Flynn,Thomas Capiris,(unknown),David T. Connor,Richard D. Dyer,Catherine R. Kostlan,D E Nies,Denis J. Schrier,Jagadish C. Sircar	34
19	Thein vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethylethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl) ethenyl]phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase 1989 ·Inflammation Research ·Denis J. Schrier,(unknown),Amal M. Boctor,Catherine R. Kostlan,Darren Flynn,(unknown),Mark E. Lesch,(unknown)	3
20	8-amino-9-substituted guanines: Potent purine nucleoside phosphorylase (PNP) inhibitors 1987 ·Inflammation Research ·Jagadish C. Sircar,Catherine R. Kostlan,(unknown),Mark J. Suto,(unknown),Thomas Capiris,Charles F. Schwender,(unknown),Mary E. Scott,Mary K. Bennett,(unknown),Richard B. Gilbertsen	19

About Catherine R. Kostlan

Catherine R. Kostlan is a scholar working on Physiology, Toxicology and Organic Chemistry, having authored 25 papers that have together received 838 indexed citations. Recurring topics across this work include Synthesis and biological activity (8 papers), Synthesis and Reactions of Organic Compounds (8 papers) and Nail Diseases and Treatments (5 papers). The work is most often cited by research in Organic Chemistry (589 citations), Pharmacology (129 citations) and Physiology (34 citations). Catherine R. Kostlan has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Denis J. Schrier, Richard D. Dyer, Michael D. Mullican, Michael W. Wilson, Jagadish C. Sircar, David T. Connor, Clifford D. Wright, Wiaczeslaw A. Cetenko, Paul C. Unangst and Roderick J. Sorenson. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact